Has Lydia Pecker, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,580 in general payments to Lydia Pecker, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lydia Pecker, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lydia Pecker, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lydia Pecker, MD

Pediatric Hematology-Oncology · Baltimore, MDNPI 1891074233

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,401 of the $40,580 with a category attached, or 65.1%. 5 manufacturers reported payments, led by Pfizer at 52.0% of the total. Among pediatric hematology-oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,580in general payments, 2019–2025

Across 27 payments — averaging $1502.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$21K
Novo Nordisk$12K
Global Blood Therapeutics, Inc.$5K
AstraZeneca$1K
E.r. Squibb & Sons, L.L.C.$551

$47,329in research payments, 2019–2025

Across 3 payments — averaging $15,776 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$46K
Novartis$945

What the payments were for

Consulting fees$26,40165%
Speaking & faculty fees$7242%
Travel & lodging$12,92032%
Food & beverage$5351%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	7	$21,082
Novo Nordisk	7	$12,135
Global Blood Therapeutics, Inc.	2	$5,401
AstraZeneca	6	$1,410
E.r. Squibb & Sons, L.L.C.	5	$551

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OXBRYTA$5,401

How this compares

$40,580 in reported general payments places this provider in the 95th percentile of 52 pediatric hematology-oncology providers in Maryland.

See all pediatric hematology-oncology providers in Maryland →

Medicare billing

Part B allowed, 2024

$2,874

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric hematology-oncology in Baltimore

Kenneth CookeBaltimore$263K
Stacy CooperBaltimore$12K
Heather SymonsBaltimore$10K
Kenneth CohenBaltimore$9K
Christine PratilasBaltimore$3K
Jennifer Keates-BaleeiroBaltimore$3K
Eric RaabeBaltimore$3K
John LigonBaltimore$2K
Cara RabikBaltimore$2K
Challice BonifantBaltimore$2K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →